Dr. Ameet P. Patel, MD

Dr. Patel practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida.

Dr. Patel's NPI, 1548623903, was assigned on April 3, 2016. Dr. Patel graduated from University Of Florida College Of Medicine in 2016. Dr. Patel holds Ohio license 35145374.

Dr. Patel's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1708 Cape Coral W Pkwy, Cape Coral, FL 33914 in Lee County. The practice phone is (239) 541-4633.

Dr. Patel's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in Cape Coral, Florida. Dr. Patel is also affiliated with BayCare St. Anthony's Hospital. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Patel to 4 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Patel practices, 6 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Patel's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Patel is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Patel's licenses on file in 4 states: Ohio, Florida, Minnesota and Tennessee.

Dmand AI lists anemia, chronic anemia, deep vein thrombosis (DVT), gastroenteritis, immune deficiency disease, insomnia, kidney failure and neutropenia among the conditions Dr. Patel treats.

CMS data shows 5,103 Medicare services from Dr. Patel across 28 procedure codes in 2024, for 298 Medicare patients. Medicare paid $139,710 for them.

CMS counts 298 Medicare patients who saw Dr. Patel in 2024. The largest group is 65 to 74, with 140 patients. 75% of them have high blood pressure, and 72% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.75, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Patel's median patient age at 70, with 57% women.

In 2024, Dr. Patel wrote 1,140 Medicare Part D claims for 194 patients. 76% of them were for generic drugs. CMS names the drug for 784 of them, across 33 drugs with 11 or more claims each, at $2,233,700 in total drug cost. In 2023, CMS named 1,042 claims across 36 drugs.

Dr. Patel accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Patel as offering telehealth.

Dmand AI links 1 paper to Dr. Patel. Dr. Patel's most frequent co-authors are Linda T. Le-Wendling, MD and Patrick James Tighe, MD.

Dmand AI links Dr. Patel to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Lymphoma, Large B-Cell, Diffuse and Lymphoma, B-Cell. Open Payments lists research payments to Dr. Patel that name 1 trial.

CMS Open Payments shows 113 general payments to Dr. Patel from 39 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,161. It also lists 4 research payments totaling $180 in 2023, naming 1 clinical trial.

Dr. Patel graduated from University Of Florida College Of Medicine in 2016.

Dr. Patel is in network with 18 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.